This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
New pneumonia vaccine aims to curb deadly pneumococcus
Merck Sharp & Dohme introduces Pneumovax, a new vaccine licensed by the FDA to combat pneumococcal pneumonia. Field trials show about 90 percent effectiveness against 14 targeted types. One million shots will be released February 1 with five million in circulation by month end. The shot provides at least three years protection and aims to reduce fatalities among high risk groups.
MENTIONED IN THIS ARTICLE
Food and Drug Administration
America
South Africa
Chile
United States
New Guinea